2462-32-0

Basic information

• Product Name: L-Phenylalanine benzyl ester hydrochloride
• Synonyms: benzyl 3-phenyl-L-alaninate hydrochloride;L-Phenylalanine Benzyl Ester HCl;Phenylalanine, benzyl ester hydrochloride;H-PHE-OBZL.HCI;H-L-Phe-OBzl*HCl;Nsc522226;l-phenylalanine benzyl ester hydrovhloride;H-Phe-OBzl hydrochloride
• CAS NO: 2462-32-0
• Molecular Formula: C₁₆H₁₇NO₂*ClH
• Molecular Weight: 291.77
• EINECS: 219-558-3
• Product Categories: Amino Acid Derivatives;Amino Acids;Phenylalanine [Phe, F];Amino Acids and Derivatives;Amino Acid Benzyl Esters;Amino Acids (C-Protected);Biochemistry;Amino hydrochloride;Amino Acid Derivatives;Peptide Synthesis;Phenylalanine
• Mol File: 2462-32-0.mol
• Article Data: 12

Chemical Properties

• Melting Point: 197-200 °C
• Boiling Point: 382.8 °C at 760 mmHg
• Flash Point: 220.4 °C
• Appearance: White to off-white/Crystalline Powder
• Vapor Pressure: 4.62E-06mmHg at 25°C
• Refractive Index: -12 ° (C=1, 80% acetic acid)
• Storage Temp.: Store at RT.
• Water Solubility: Soluble in water
• BRN: 3919200
• CAS DataBase Reference: L-Phenylalanine benzyl ester hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine benzyl ester hydrochloride(2462-32-0)
• EPA Substance Registry System: L-Phenylalanine benzyl ester hydrochloride(2462-32-0)

Safety Data

• Safety Statements: 22-24/25
• WGK Germany: 3
• Hazardous Substances Data: 2462-32-0(Hazardous Substances Data)

Usage

Chemical Properties

White crystal

Uses

L-Phenylalanine Benzyl Ester Hydrochloride is a commonly used reactant for the synthesis of L-isoserine derivatives as aminopeptidase N inhibitors and PF-04449913 as a potent and orally bioavailable inhibitor of smoothened.

InChI:InChI=1/C16H17NO2.ClH/c17-15(11-13-7-3-1-4-8-13)16(18)19-12-14-9-5-2-6-10-14;/h1-10,15H,11-12,17H2;1H/t15-;/m0./s1

Upstream product

• 66617-58-1 N-(tert-butoxycarbonyl)-L-phenylalanine benzyl ester 
• 100-51-6 benzyl alcohol 
• 13734-34-4 N-tert-butoxycarbonyl-L-phenylalanine 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 58780-66-8 phenylalanine benzyl ester hydrochloride 
• 63-91-2 L-phenylalanine 
• 2688-22-4 Nps-L-Phe-OH 
• 84673-44-9 (S)-2-(2-Nitro-phenylsulfanylamino)-3-phenyl-propionic acid benzyl ester 

Downstream Products

• 97831-87-3 Carbobenzoxy-(N^ε-tosyl)-lysyl-phenylalaninbenzylester 
• 74257-60-6 (S)-tert-butyl 2-((S)-1-(benzyloxy)-1-oxo-3-phenylpropan-2-ylcarbamoyl)pyrrolidine-1-carboxylate 
• 104225-79-8 (S)-2-{[1-Naphthalen-1-yl-meth-(Z)-ylidene]-amino}-3-phenyl-propionic acid benzyl ester 
• 70669-39-5 Phe-Phe-OBzl 
• 133389-04-5 Z-Nle-His-Phe-OBzl 
• 103256-24-2 (S)-2-[(S)-2-(2-{[(S)-1-((S)-1-Ethoxycarbonyl-2-phenyl-ethylcarbamoyl)-2-phenyl-ethylcarbamoyl]-methoxy}-acetylamino)-3-phenyl-propionylamino]-3-phenyl-propionic acid ethyl ester 
• 123198-12-9 3,4-dibenzyloxybenzoyl-Ala-Phe-OBzl 
• 140834-91-9 (S)-benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate 
• 92411-01-3 Boc-His-Phe-OBzl 
• 62056-98-8 C₂₈H₂₆NO₃P 
• 2577-41-5 (S)-benzyl 2-((S)-2-(((benzyloxy)carbonyl)amino)-3-phenylpropanamido)-3-phenylpropanoate 
• 138108-43-7 Boc-Asp(OBzl)-Phe-OBzl 

Relevant articles and documents

Fluorinated epoxyketone-based compounds and uses thereof as proteasome inhibitors

The present application relates to novel fluorinated epoxyketone-based compounds, compositions comprising these compounds and their use, in particular for the treatment of diseases, disorders or conditions mediated by proteasome inhibition, in particular, the present application includes compounds of Formula I, and compositions and uses thereof.

Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors

A series of novel L-isoserine derivatives were synthesised and evaluated for their ability to inhibit aminopeptidase N (APN)/CD13. In our preliminary biological results, some of these compounds possessed a potent inhibitory activity against the APN. Within this series, compound 14b not only showed similar enzyme inhibition (IC50 of 12.2μM) compared with the positive control bestatin (half maximal inhibitory concentration (IC 50) of 7.3μM), but also had a potent antiproliferative activity against human cancer cell lines cells.

COMPOSITIONS AND METHODS FOR CYCLOFRUCTANS AS SEPARATION AGENTS

The present invention relates to derivatized cyclofructan compounds, compositions comprising derivatized cyclofructan compounds, and methods of using compositions comprising derivatized cyclofructan compounds for chromatographic separations of chemical species, including enantiomers. Said compositions may comprise a solid support and/or polymers comprising derivatized cyclofructan compounds.